Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Leuk Lymphoma. 2012 Sep 12;54(3):665–668. doi: 10.3109/10428194.2012.720375

Figure 1. Cumulative Incidence of Relapse/Progression.

Figure 1

The cumulative incidence curves for bone marrow relapse/progression (n=76, solid line) and extramedullary relapse/progression (n=18, dashed line) are plotted from the date of transplantation (in years). The 18 extramedullary relapses include 5 patients with concurrent bone marrow relapse. Curves were calculated using non-relapse mortality as a competing risk.